Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Chirurgica Latviensis

The Journal of Riga Stradins University; Latvian Association of Surgeons; Latvian Association of Paediatric Surgeons

2 Issues per year

Open Access
Online
ISSN
2199-5737
See all formats and pricing
More options …

Pathology of Breast Cancer: from Classic Concepts to Molecular Pathology and Pathogenesis

Ilze Strumfa
  • Corresponding author
  • Department of Pathology, Riga Stradins University, Riga, Latvia
  • Institute of Oncology, Riga Stradins University, Riga, Latvia
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Andrejs Vanags / Arnis Abolins / Janis Gardovskis
  • Institute of Oncology, Riga Stradins University, Riga, Latvia
  • Department of Surgery, Riga Stradins University, Riga, Latvia
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-05-11 | DOI: https://doi.org/10.2478/v10163-012-0012-x

Summary

Breast cancer has high incidence and still significant mortality. Due to the widespread application and efficacy of surgery in breast cancer treatment, the surgeon has a crucial role in the treatment planning. Taking into account the tendency to personalized cancer care and the heterogeneity of breast cancer, the surgeon has to be aware about the prognostic and predictive characteristics of breast cancer. We discuss here the classaic pathology of breast cancer along with molecular subtypes, novel prognostic markers and molecular pathogenesis.

Keywords : breast cancer; pathology; molecular pathology; molecular subtypes; immunohistochemistry

  • 1. Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules // PLos One, 2011; 6(11):e27339 CrossrefGoogle Scholar

  • 2. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O’Connell P, Tsimelzon A, Medina D. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution // Clin Cancer Res, 2008; 14:370 - 378 Web of ScienceCrossrefGoogle Scholar

  • 3. Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression // J Pathol, 2011; 223: 307 - 317 Google Scholar

  • 4. Bostrom P, Soderstrom M, Vahlberg T, Soderstrom KO, Roberts PJ, Carpen O, Hirsimaki P. MMP-1 expression has an independent prognostic value in breast cancer // BMC Cancer, 2011; 11:348 CrossrefGoogle Scholar

  • 5. Buerger H, Otterback F, Simon R, Schafer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn- Dworniczak B, Boecker W. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes // J Pathol, 1999; 189: 521 - 526 Google Scholar

  • 6. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC. Race, breast cancer subtypes, and survival in the Carolina breast cancer study // J Am Med Assoc, 2006; 295: 2492 - 2502 Google Scholar

  • 7. Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO. Ki-67 index, HER2 status, and prognosis of patients with luminal B breast cancer // J Natl Cancer Inst, 2009; 101:736 - 750 CrossrefGoogle Scholar

  • 8. Farmer P, Bonnefoi H, Becette V, Tubiana- Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R. Identification of molecular apocrine breast tumours by microarray analysis // Oncogene, 2005; 24:4660 - 4671 CrossrefGoogle Scholar

  • 9. Gabos Z, Sinha R, Hanson J, Chauhen N, Hugh J, Mackey JR, Abdulkarim B. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breats cancer // J Clin Oncol, 2006; 24(36):5658 - 5663 CrossrefGoogle Scholar

  • 10. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ; Panel members. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 // Ann Oncol, 2011; 22(8):1736 - 1747 CrossrefWeb of ScienceGoogle Scholar

  • 11. Guarneri V, Conte PF. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy // The Oncologist, 2009; 14:645 - 656 CrossrefGoogle Scholar

  • 12. Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Epigenetics in breast cancer: what’s new? // Breast Cancer Res, 2011; 13:225. CrossrefGoogle Scholar

  • 13. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cell and their dynamic equilibrium with non-stem cancer cells via IL6 secretion // Proc Natl Acad Sci USA. 2011; 108(4):1397 - 1402 CrossrefGoogle Scholar

  • 14. Kang JH, Song KH, Jeong KC, Kim S, Choi C, Lee CH, Oh SH. Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells // BMC Cancer, 2011; 11:334 Web of ScienceGoogle Scholar

  • 15. Malhotra GK, Zhao X, Band H, Band V. Histological, molecular and functional subtypes of breast cancers // Cancer Biol Ther, 2010; 10(10):955 - 960 CrossrefGoogle Scholar

  • 16. Natrajan R, Lambros MB, Geyer FC, Marchio C, tan DS, Vatcheva R, Shiu KK, Hungermann D, Rodriguez-Pinilla SM, Palacios J, Ashworth A, Buerger H, Reis-Filho JS. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: evidence for progression in tumors with luminal phenotype? // Genes Chromosomes Cancer, 2009; 48:351 - 365 Web of ScienceCrossrefGoogle Scholar

  • 17. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma // Clin Cancer Res, 2004; 10: 5367 - 5374 CrossrefGoogle Scholar

  • 18. Nielsen TO, Parker JS, Leung S. Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J, Cheang MC, Mardis ER, Perou CM, Bernard PS, Ellis MJ. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer // Clin Cancer Res, 2010; 16:5222 - 5232 CrossrefGoogle Scholar

  • 19. Nowell PC. The clonal evolution of tumor cell populations // Science, 1976; 194:23 - 28 Google Scholar

  • 20. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS. Supervised risk predictor of breast cancer based on intrinsic subtypes // J Clin Oncol, 2009; 27:1160 - 1167 CrossrefWeb of ScienceGoogle Scholar

  • 21. Peppercorn J, Perou CM, Carey LA. Molecular subtypes in breast cancer evaluation and management: divide and conguer // Cancer Invest, 2008; 26:1 - 10 Web of ScienceCrossrefGoogle Scholar

  • 22. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portreits of human breast tumours // Nature, 2000; 406: 747 - 752 Web of ScienceGoogle Scholar

  • 23. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER2-overexpressing and triple-negative breast cancer // Cancer, 2008; 113(7):1521 - 1526 Google Scholar

  • 24. Place AE, Huh SJ, Polyak K. The microenvironment in breast cancer progression: biology and implications for treatment // Breast Cancer Res, 2011; 13:227 CrossrefWeb of ScienceGoogle Scholar

  • 25. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowith JI, He X, Perous CM. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer // Breast cancer Res, 2010; 12:R68. CrossrefWeb of ScienceGoogle Scholar

  • 26. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells // Nature, 2001; 414:105 - 111 Google Scholar

  • 27. Reyal F, Rouzier R, Depont-Hazelzet B, Bollet MA, Pierga JY, Alran S, Salmon RJ, Fourchotte V, Vincent-Salomon A, Sastre-Garau X, Antoine M, Uzan S, Sigal-Zafrani B, De Rycke Y. The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma // PLoS One, 2011; 6(5):e20297. CrossrefWeb of ScienceGoogle Scholar

  • 28. Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, Sheer D. Comparative genomic hybridization of breast tumors stratified by histologic grade reveals new insights into the biological progression of breast cancer // Cancer Res, 1999; 59:1433 - 1463 Google Scholar

  • 29. Rozier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L. Breast cancer molecular subtypes respond differently to preoperative chemotherapy // Clin Cancer Res, 2005; 11(16):5678 - 5685 CrossrefGoogle Scholar

  • 30. Sorlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities // Eur J Cancer, 2004; 40:2667 - 2675 CrossrefGoogle Scholar

  • 31. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale Al. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications // Proc Natl Acad Sci USA, 2001; 98:10869 - 10874 CrossrefGoogle Scholar

  • 32. Strehl JD, Wachter DL, Fasching PA, Beckmann MW, Hartmann A. Invasive breast cancer: Recognition of molecular subtypes // Breast Care, 2011; 6:258 - 264 Web of ScienceGoogle Scholar

  • 33. Tan J, Buache E, Chenard MP, Dali-Youcef, Rio MC. Adipocyte is a non-trivial, dynamic partner of breast cancer cells // Int J Dev Biol, 2011; 55:851 - 859 CrossrefWeb of ScienceGoogle Scholar

  • 34. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse // J Clin Oncol, 2010; 28(10):1684 - 1691 CrossrefGoogle Scholar

  • 35. Zaha DC, Lazar E. Molecular characterization of apoptosis by the immunohistochemical evaluation of Bcl-2 in breast cancer // Rom J Morphol Embryol, 2012; 53(1): 155 - 160 Google Scholar

  • 36. Wander SA, Zhao D, Slingerland JM. P27: a barometer of signalind deregulation and potential predictor of response to targeted therapies // Clin Cancer Res, 2011; 17(1):12 - 18 Web of ScienceCrossrefGoogle Scholar

  • 37. Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, Ashworth A, Reis-Filho JS. Breast cancer molecular profiling with single sample predictors: a retrospective analysis // Lancet Oncol, 2010; 11(4):339 - 349 Web of ScienceCrossrefGoogle Scholar

About the article

Published Online: 2013-05-11

Published in Print: 2012-12-01


Citation Information: Acta Chirurgica Latviensis, ISSN (Print) 1407-981X, DOI: https://doi.org/10.2478/v10163-012-0012-x.

Export Citation

This content is open access.

Comments (0)

Please log in or register to comment.
Log in